Design Therapeutics (DSGN) Financial Statements
Price: $3.49
Market Cap: $198.10M
Avg Volume: 151.28K
Market Cap: $198.10M
Avg Volume: 151.28K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Design Therapeutics.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Revenue | $- | $- | $- | $- | $226 | $834 |
| Cost of Revenue | $- | $537.00K | $466.00K | $129.00K | $5.00K | $1.65K |
| Gross Profit | $- | $-537.00K | $-466.00K | $-129.00K | $-4.77K | $-820 |
| Gross Profit Ratio | 0.00% | - | - | - | -2112.39% | -98.32% |
| Research and Development Expenses | $44.35M | $57.06M | $48.61M | $24.78M | $6.06M | $1.65M |
| General and Administrative Expenses | $18.03M | $21.13M | $18.98M | $11.05M | $2.50M | $1.09M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $18.03M | $21.13M | $18.98M | $11.05M | $2.50M | $1.09M |
| Other Expenses | $- | $- | $4.29M | $298.00K | $-226.00K | $-834.00K |
| Operating Expenses | $62.38M | $78.19M | $67.59M | $35.83M | $8.33M | $1.91M |
| Cost and Expenses | $- | $78.19M | $67.59M | $35.83M | $8.33M | $1.91M |
| Interest Income | $12.79M | $- | $- | $- | $- | $- |
| Interest Expense | $- | $- | $- | $- | $- | $- |
| Depreciation and Amortization | $- | $537.00K | $466.00K | $129.00K | $5.00K | $1.91M |
| EBITDA | $-62.38M | $-66.33M | $-62.84M | $-35.70M | $-8.32M | $-139.00K |
| EBITDA Ratio | - | - | - | - | -3683628.32% | -16666.67% |
| Operating Income | $-62.38M | $-78.19M | $-67.59M | $-35.83M | $-8.33M | $-1.91M |
| Operating Income Ratio | - | - | - | - | -3685840.71% | -228776.98% |
| Total Other Income Expenses Net | $12.79M | $11.33M | $4.29M | $298.00K | $50.00K | $-139.00K |
| Income Before Tax | $-49.59M | $-66.86M | $-63.31M | $-35.53M | $-8.28M | $-2.05M |
| Income Before Tax Ratio | - | - | - | - | -3663716.81% | -245443.65% |
| Income Tax Expense | $- | $-1 | $-4.69M | $-107.56K | $-201.30K | $-1.91K |
| Net Income | $-49.59M | $-66.86M | $-58.62M | $-35.53M | $-8.28M | $-2.05M |
| Net Income Ratio | - | - | - | - | -3663716.81% | -245443.65% |
| EPS | $-0.88 | $-1.19 | $-1.05 | $-0.77 | $-0.30 | $-0.08 |
| EPS Diluted | $-0.88 | $-1.19 | $-1.05 | $-0.77 | $-0.30 | $-0.08 |
| Weighted Average Shares Outstanding | 56.59M | 55.98M | 55.71M | 45.94M | 27.19M | 27.19M |
| Weighted Average Shares Outstanding Diluted | 56.59M | 55.98M | 55.71M | 45.94M | 27.19M | 27.19M |
| SEC Filing | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $22.56M | $21.20M | $26.50M | $298.57M | $2.38M | $77.00K |
| Short Term Investments | $222.91M | $260.60M | $303.89M | $85.50M | $33.71M | $- |
| Cash and Short Term Investments | $245.48M | $281.80M | $330.39M | $384.06M | $36.09M | $77.00K |
| Net Receivables | $- | $1.43M | $1.11M | $110.00K | $10.00K | $- |
| Inventory | $- | $- | $-1.11M | $1.25M | $107.00K | $- |
| Other Current Assets | $2.56M | $1.35M | $8.35M | $1.26M | $132.00K | $5.00K |
| Total Current Assets | $248.04M | $284.58M | $335.12M | $385.44M | $36.23M | $90.00K |
| Property Plant Equipment Net | $3.63M | $4.63M | $5.56M | $5.12M | $71.00K | $- |
| Goodwill | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $- | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $427.00K | $430.00K | $459.00K | $- | $212.00K | $- |
| Total Non-Current Assets | $4.05M | $5.06M | $6.02M | $5.12M | $283.00K | $- |
| Other Assets | $- | $- | $- | $- | $- | $- |
| Total Assets | $252.09M | $289.64M | $341.14M | $390.56M | $36.52M | $90.00K |
| Account Payables | $2.19M | $1.94M | $3.02M | $1.62M | $1.40M | $2.48M |
| Short Term Debt | $- | $716.00K | $640.00K | $489.00K | $- | $695.00K |
| Tax Payables | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $- | $- | $201.00K |
| Other Current Liabilities | $6.28M | $6.97M | $7.11M | $3.17M | $931.00K | $356.00K |
| Total Current Liabilities | $8.46M | $9.62M | $10.78M | $5.28M | $2.33M | $3.73M |
| Long Term Debt | $1.53M | $2.33M | $6.10M | $6.29M | $- | $- |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $- | $- | $-3.05M | $-3.14M | $45.50M | $1.00K |
| Total Non-Current Liabilities | $1.53M | $2.33M | $3.05M | $3.14M | $45.50M | $1.00K |
| Other Liabilities | $- | $- | $- | $- | $- | $-0 |
| Total Liabilities | $10.00M | $11.96M | $13.83M | $8.43M | $47.83M | $3.73M |
| Preferred Stock | $- | $- | $- | $390.56M | $45.36M | $- |
| Common Stock | $6.00K | $6.00K | $6.00K | $6.00K | $1.00K | $1.00K |
| Retained Earnings | $-227.21M | $-177.63M | $-110.76M | $-47.46M | $-11.92M | $-3.64M |
| Accumulated Other Comprehensive Income Loss | $475.00K | $62.00K | $-3.36M | $-244.00K | $156.00K | $- |
| Other Total Stockholders Equity | $468.83M | $455.25M | $441.42M | $429.82M | $-44.91M | $- |
| Total Stockholders Equity | $242.10M | $277.69M | $327.31M | $382.13M | $-11.31M | $-3.64M |
| Total Equity | $242.10M | $277.69M | $327.31M | $382.13M | $-11.31M | $-3.64M |
| Total Liabilities and Stockholders Equity | $252.09M | $289.64M | $341.14M | $390.56M | $36.52M | $90.00K |
| Minority Interest | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $252.09M | $289.64M | $341.14M | $390.56M | $36.52M | $90.00K |
| Total Investments | $222.91M | $260.60M | $303.89M | $85.50M | $33.71M | $- |
| Total Debt | $1.53M | $3.05M | $3.69M | $3.63M | $- | $695.00K |
| Net Debt | $-21.03M | $-18.15M | $-22.81M | $-294.94M | $-2.38M | $618.00K |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Net Income | $-49.59M | $-66.86M | $-63.31M | $-35.53M | $-8.28M | $-2.05M |
| Depreciation and Amortization | $-5.60M | $537.00K | $406.00K | $129.00K | $5.00K | $- |
| Deferred Income Tax | $- | $- | $- | $-77.00K | $-71.00K | $- |
| Stock Based Compensation | $13.07M | $13.09M | $10.93M | $4.69M | $450.00K | $- |
| Change in Working Capital | $-993.00K | $728.00K | $1.99M | $1.40M | $-811.00K | $1.81M |
| Accounts Receivables | $- | $- | $- | $- | $- | $- |
| Inventory | $- | $- | $- | $- | $- | $- |
| Accounts Payables | $-1.22M | $-1.25M | $5.38M | $2.41M | $-413.00K | $- |
| Other Working Capital | $226.00K | $1.97M | $-3.39M | $-1.02M | $-398.00K | $1.81M |
| Other Non Cash Items | $6.00K | $-6.05M | $-1.33M | $19.00K | $38.00K | $95.00K |
| Net Cash Provided by Operating Activities | $-43.10M | $-58.56M | $-51.32M | $-29.38M | $-8.67M | $-139.00K |
| Investments in Property Plant and Equipment | $-340.00K | $-256.00K | $-918.00K | $-1.54M | $-76.00K | $- |
| Acquisitions Net | $- | $- | $39.00K | $52.11K | $33.48K | $- |
| Purchases of Investments | $-230.18M | $-224.70M | $-313.00M | $-86.26M | $-55.59M | $- |
| Sales Maturities of Investments | $274.47M | $277.50M | $92.89M | $34.16M | $22.10M | $- |
| Other Investing Activities | $- | $- | $39.00K | $-52.11K | $-33.48K | $- |
| Net Cash Used for Investing Activities | $43.95M | $52.54M | $-220.99M | $-53.64M | $-33.56M | $- |
| Debt Repayment | $- | $- | $- | $- | $44.53M | $196.00K |
| Common Stock Issued | $- | $724.00K | $662.00K | $254.27M | $1.00K | $- |
| Common Stock Repurchased | $477.00K | $305.00K | $339.00K | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $513.00K | $724.00K | $235.00K | $124.94M | $1.00K | $- |
| Net Cash Used Provided by Financing Activities | $513.00K | $724.00K | $235 | $379.21K | $44.53M | $196.00K |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $1.36M | $-5.30M | $-272.07M | $296.19M | $2.30M | $57.00K |
| Cash at End of Period | $22.56M | $21.20M | $26.50M | $298.57M | $2.38M | $77.00K |
| Cash at Beginning of Period | $21.20M | $26.50M | $298.57M | $2.38M | $77.00K | $20.00K |
| Operating Cash Flow | $-43.10M | $-58.56M | $-51.32M | $-29.38M | $-8.67M | $-139.00K |
| Capital Expenditure | $-340.00K | $-256.00K | $-918.00K | $-1.54M | $-76.00K | $- |
| Free Cash Flow | $-43.45M | $-58.82M | $-52.23M | $-30.91M | $-8.74M | $-139.00K |